PSTV רווחיות תפעולית Plus Therapeutics Inc

סמלים רשמיים של חברת Plus Therapeutics Inc (PSTV)

Asset volatility for Plus Therapeutics, Inc. (PSTV) is driven by the development of radiotherapy to combat breast and brain tumors. The operating margin curve on the GURU.Markets platform chart shows that the current metric is -364.40. While insurance payments for high-tech treatment provide stability, the lack of recurring revenue due to early-stage drug trials creates typical biotech risks.

PSTV - שיעור רווח תפעולי Plus Therapeutics, Inc. בטווח 04.07.2022 - 03.08.2026

Plus Therapeutics Inc - פילוחים אנליטיים ומדדי מפתח (PSTV)

ניתוח פונדמנטלי של החברה:PSTV, Plus Therapeutics Inc
מוצרים מוגמרים של Plus Therapeutics

Investors evaluate operational efficiency by analyzing the share of operating profit relative to total EBITDA. For Plus Therapeutics, Inc. (PSTV), whose radiopharmaceuticals are currently in clinical trials without a stable cash flow, the operating profit margin reflects high project development costs and a lack of self-sustaining cash.